These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 23979164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells.
    Gao XN, Lin J, Ning QY, Gao L, Yao YS, Zhou JH, Li YH, Wang LL, Yu L.
    PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
    Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC.
    Leukemia; 2016 Mar; 30(3):728-39. PubMed ID: 26449661
    [Abstract] [Full Text] [Related]

  • 10. MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Prange KHM, Mandoli A, Kuznetsova T, Wang SY, Sotoca AM, Marneth AE, van der Reijden BA, Stunnenberg HG, Martens JHA.
    Oncogene; 2017 Jun 08; 36(23):3346-3356. PubMed ID: 28114278
    [Abstract] [Full Text] [Related]

  • 11. Cooperation between RUNX1-ETO9a and novel transcriptional partner KLF6 in upregulation of Alox5 in acute myeloid leukemia.
    DeKelver RC, Lewin B, Lam K, Komeno Y, Yan M, Rundle C, Lo MC, Zhang DE.
    PLoS Genet; 2013 Jun 08; 9(10):e1003765. PubMed ID: 24130502
    [Abstract] [Full Text] [Related]

  • 12. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation.
    Bäsecke J, Schwieger M, Griesinger F, Schiedlmeier B, Wulf G, Trümper L, Stocking C.
    Leuk Lymphoma; 2005 Feb 08; 46(2):265-72. PubMed ID: 15621811
    [Abstract] [Full Text] [Related]

  • 13. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R, Zaidi SK, Pande S, Hassan MQ, Young DW, Montecino M, Lian JB, van Wijnen AJ, Stein JL, Stein GS.
    J Cell Sci; 2008 Dec 01; 121(Pt 23):3981-90. PubMed ID: 19001502
    [Abstract] [Full Text] [Related]

  • 14. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
    Zaidi SK, Perez AW, White ES, Lian JB, Stein JL, Stein GS.
    Oncotarget; 2017 Jun 20; 8(25):39994-40005. PubMed ID: 28611288
    [Abstract] [Full Text] [Related]

  • 15. Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.
    Matsuura S, Yan M, Lo MC, Ahn EY, Weng S, Dangoor D, Matin M, Higashi T, Feng GS, Zhang DE.
    Blood; 2012 Mar 29; 119(13):3155-63. PubMed ID: 22223820
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia.
    Yang E, Guan W, Gong D, Gao X, Han C, Zhang J, Wang H, Wang M, Li Y, Yu L.
    Clin Sci (Lond); 2020 Dec 11; 134(23):3079-3091. PubMed ID: 33201243
    [Abstract] [Full Text] [Related]

  • 17. KRAS (G12D) cooperates with AML1/ETO to initiate a mouse model mimicking human acute myeloid leukemia.
    Zhao S, Zhang Y, Sha K, Tang Q, Yang X, Yu C, Liu Z, Sun W, Cai L, Xu C, Cui S.
    Cell Physiol Biochem; 2014 Dec 11; 33(1):78-87. PubMed ID: 24480914
    [Abstract] [Full Text] [Related]

  • 18. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
    Dayyani F, Wang J, Yeh JR, Ahn EY, Tobey E, Zhang DE, Bernstein ID, Peterson RT, Sweetser DA.
    Blood; 2008 Apr 15; 111(8):4338-47. PubMed ID: 18258796
    [Abstract] [Full Text] [Related]

  • 19. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion.
    Yun JW, Bae YK, Cho SY, Koo H, Kim HJ, Nam DH, Kim SH, Chun S, Joo KM, Park WY.
    Int J Mol Sci; 2019 Apr 06; 20(7):. PubMed ID: 30959925
    [Abstract] [Full Text] [Related]

  • 20. RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1).
    Hyde RK, Liu PP.
    J Cell Biochem; 2010 Aug 01; 110(5):1039-45. PubMed ID: 20589720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.